Arkolith/Insider Trading/CELU/Form 4

Ling Geoffrey M.D.

DirectorCelularity Inc (CELU) · full profile →Form 4 · filed Jan 6, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2024Grant(A)67K—$067K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 19, 2024Grant(A)85K—$01.3M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-001099) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML